¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ The Liver Week 2023 Day 2 : 2023-05-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ°£ÇÐȸ The Liver Week 2023 Day 2 : 2023-05-19
±³À°ÀÏÀÚ : 2023-05-19
±³À°Àå¼Ò : ÀÎõ ±×·£µåÇϾæÆ® È£ÅÚ ROOM ABC [B1F] Grand Ballroom I+II ¿Ü 4°³·ë

±³À°ÁÖÁ¦ : The Liver Week 2023 Day 2

ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-707-0091  

À̸ÞÀÏ : kasl@kams.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ÀÎõ±¤¿ª½Ã
±³À°½Ã°£ : 27 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 140,000¿ø  

ºñ°í [TLW]Member-140,000/ Resident, Trainee, Fellow, Researcher, Army Doctor, Nurse, or Others-80,000 Non-Member, Healthcare Professional-170,000 International Delegate-USD 150 Foreign Investigator Award Winner-USD 40[PG]Member-50,000/ Resident, Trainee, Fellow, Researcher, Army Doctor, Nurse, or Others-30,000 Non-Member, Healthcare Professional-60,000

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 08:30~08:45 Advances in the Treatment of Severe Alcoholic Hepatitis Young Kul Jung(Korea Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 08:45~09:00 Nonalcoholic Fatty Liver Disease vs. Metabolic Associated Fatty Liver Disease: Which One Reflects More Clinical Aspects? Ming-Hua Zheng (Wenzhou Medical Univ., China)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 09:00~09:15 Is Moderate Alcohol Intake Really Safe for Nonalcoholic Fatty Liver Disease Patients Dae Won Jun(Hanyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 09:15~09:30 Anti-Diabetic Treatment for Nonalcoholic Fatty Liver Disease Patients with Prediabetes and Type 2 Diabetes Yoshio Sumida(Aichi Medical Univ., Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 11:10~11:25 Hepatocellular Carcinoma Risk and Prediction Model in Patients with Chronic Hepatitis B Virus Infection Hyung Joon Yim(Korea Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 11:25~11:40 Hepatocellular Carcinoma Surveillance after Sustained Virologic Response in Chronic Hepatitis C: Is It Necessary? Carla S. Coffin(Univ. of Calgary, Canada)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 11:40~11:55 Defining Target Populations with Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease for Hepatocellular Carcinoma Surveillance Yoshio Sumida(Aichi Medical Univ., Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 11:55~12:10 Novel Surveillance Tools for the Detection of Early Hepatocellular Carcinoma: Beyond Ultrasound and/or Serum Alpha-Fetoprotein Do Young Kim(Yonsei Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 13:20~13:50 Toward a Functional Cure for Hepatitis B Virus Anna Suk-Fong Lok(Univ. of Michigan, USA)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 13:50~14:10 Natural Course and Prognosis in Patients with Nonalcoholic Fatty Liver Disease W. Ray Kim (Stanford Univ, USA)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 14:10~14:30 Role of Genetics in Nonalcoholic Fatty Liver Disease Won Kim(Seoul National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 14:30~14:50 Diet and Nutritional Management in Nonalcoholic Fatty Liver Disease Hwi Young Kim(Ewha Womans Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 14:50~15:10 Recent Updates on Pharmacologic Therapy in Nonalcoholic Fatty Liver Disease Manal F. Abdelmalek(Mayo Clinic, USA)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 16:10~16:25 Porto-Sinusoidal Vascular Disease: A Novel Entity Maria Guido(Univ. of Padua, Italy)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 16:25~16:40 Tips for the Rapid Radiologic Diagnosis of Non-Cirrhotic Vascular Liver Diseases Joon-Il Choi (The Catholic Univ. of Korea)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 16:40~16:55 Optimal Treatment of Budd-Chiari Syndrome Akash Shukla (Seth GSMC & KEM Hospital, India)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 16:55~17:10 Benign Portal Vein Thrombosis and Options for Anticoagulation Hwi Young Kim(Ewha Womans Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 17:10~17:25 Viral Hepatitis: Individualization of Hepatocellular Carcinoma Prevention Strategy in Chronic Viral Hepatitis Gi-Ae Kim(Kyung Hee Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 17:25~17:40 Autoimmune Hepatitis: Update of Pathologic Components in Diagnosis Haeryoung Kim(Seoul National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 17:40~17:55 Alcoholic Hepatitis: Beyond the Barriers in Initial Evaluation and Management Seong Hee Kang(Korea Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM AB]  Grand Ballroom I+II 17:55~18:10 Cirrhosis: From Endoscopic Therapy to Beta-Blockers for Variceal Bleeding Young Youn Cho (Chung-Ang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 08:30~08:45 Intrahepatic Macrophage Heterogeneity in Liver Injury Young-Sun Lee(Korea Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 08:45~09:00 The Role of Macrophages in Alcohol-Associated Liver Disease Yasuko Iwakiri(Yale Univ. USA)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 09:00~09:15 Autoimmune Hepatitis: Delicate Interplay among Th1/Th17 T Cells, CTLs, and Regulatory T Cells Pil Soo Sung (The Catholic Univ. of Korea)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 09:15~09:30 How Can We Boost T Cell Responses during Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma? Sadahisa Ogasawara(Chiba Univ., Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 11:10~11:25 Liver Function and Operative Risk Evaluation of Referred Patients Yang Hyon Baek (Dong-A Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 11:25~11:40 Simplified Treatment of Viral Hepatitis Tae Suk Kim (Kangwon National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 11:40~11:55 Management of Complications in Decompensated Cirrhosis Jung Gil Park(Yeungnam Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 11:55~12:10 Best Approach to Alcoholic Liver Disease Seung Kak Shin(Gachon Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 13:50~14:10 Opportunities and Challenges for Delivering AI and Machine Learning to Clinical Field Namkug Kim(Univ. of Ulsan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 14:10~14:30 Digital Pathology and AI in Pathological Diagnosis of Liver Disease Sung Hak Lee(The Catholic Univ. of Korea)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 14:30~14:50 Application of AI in the Diagnosis and Treatment of Hepatocellular Carcinoma Gwang Hyeon Cho(Seoul National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 14:50~15:10 Current status and Future Perspectives of Deep Learning in Liver Imaging Hyungjin Rhee(Yonsei Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 16:10~16:25 New Biomarkers to Escape the Gray Zone in the Management of Chronic Hepatitis B: HBcrAg and Hepatitis B Virus RNA Wai-Kay Seto (The Univ. of Hong Kong, Hong Kong)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 16:25~16:40 Role of Genetic Polymorphisms in the Prognosis of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Ming-Hua Zheng(Wenzhou Medical Univ., China)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 16:40~16:55 Current Knowledge about Biomarkers of Acute Kidney Injury in Liver Cirrhosis Jeong-Ju Yoo(Soonchunhyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM C]  Grand Ballroom III 16:55~17:10 Development of RNA-Based & RNA-Targeted Therapeutics in Liver Cancer Suk Woo Nam (The Catholic Univ. of Korea)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 11:10~11:25 Microbiome and Metabolomics in Nonalcoholic Fatty Liver Disease: From Bench to Bedside Ki Tae Suk(Hallym Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 11:25~11:40 Microbiome in Alcoholic Liver Disease: Mechanism and Therapeutic Role Jaeyoun Cheong(Ajou Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 11:40~11:55 Role of Gut Microbiome in Hepatocellular Carcinoma: Pathogenesis, Diagnosis, and Therapy Eun Ju Cho (Seoul National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 11:55~12:10 Gut Microbiome and Immune Homeostasis in Liver Transplantation Soon Kyu Lee(The Catholic Univ. of Korea)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 17:10~17:15 How To Become a Hepatologist in Korea Young Chang (Soonchunhyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 17:15~17:25 My Career as a Clinical Investigator in Hepatology: Perspective from a Junior Faculty Han Ah Lee(Ewha Womans Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 17:25~17:35 My Career as a Clinical Investigator in Hepatology: Perspective from a Junior Faculty Jeong-Ju Yoo(Soonchunhyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 17:35~17:45 My Journey to be a Famale Hepatologist Anna Suk-Fong Lok(Univ. of Michigan, USA)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM D] Grand Salon III 17:45~18:10 Panel Discussion ()

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 07:30~07:35 New Insights into Gut Microbiome in Decompensated Cirrhosis 1 Eileen L. Yoon(Hanyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 07:35~07:45 Role of Gut Microbiome in the Development of Hepatic Decompensation in Cirrhosis Ki Tae Suk(Hallym Univ)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 07:45~08:00 Discussion ()

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 08:00~08:05 New Insights into Gut Microbiome in Decompensated Cirrhosis 2 Eileen L. Yoon(Hanyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 08:05~08:15 Microbiome-Based Therapeutics in Patients with Decompensated Cirrhosis Jasmohan S. Bajaj (Virginia Commonwealth Univ., USA)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 08:15~08:30 Discussion ()

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 11:10~11:20 Implemention of the National Practice Guidelines for Hepatitis B and Hepatitis C in Korea Eileen L. Yoon(Hanyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 11:20~11:30 Investigation of Distribution by Stage at the Time of Diagnosis of Chronic Hepatitis C Patients and Development of the Disease Burden Model Seung Up Kim (Yonsei Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 11:30~11:40 Effect of Medication Adherence in Hepatitis B and C Patients via Digital Management Program Joo Hyun Oh(Eulji Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 11:40~11:50 Feasibility and Follow-Up Management of Hepatitis C Screening by National Health Checkup Program Young Chang(Soonchunhyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 11:50~12:00 Development of Viral Hepatitis (B-C) Elimination Strategy Chang Hun Lee (Jeonbuk National Univ)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 12:00~12:10 Discussion Ji Hoon Kim, Seung Up Kim, Dong Hyun Sinn, Jae Young Jang, In Hee Kim(Korea Univ, Yonsei Univ, Sungkyunkwan Univ, Soonchunhyang Univ, Jeonbuk National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 13:50~14:10 Laparoscopic Living Donor Hepatectomy Jinsoo Rhu(Sungkyunkwan Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 14:10~14:30 Robotic Living Donor Hepatectomy Dai Hoon Han(Yonsei Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 14:30~14:50 Long-Term Outcome of Living Liver Donors Jongman Kim(Sungkyunkwan Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM E] Exec. Board Room 14:50~15:10 Pre-and Postoperative Care for Living Liver Donors Jieun Lee (Severance Hospital)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM F] Pine 07:30~07:35 Role of Liquid Biopsy in the Management of Hepatocellular Carcinoma 1 Sun Young Yim(Korea Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM F] Pine 07:35~07:45 Role of Liquid Biopsy for the Detection of Early-Stage Hepatocellular Carcinoma Ju Dong Yang(Cedars Sinai Medical Center, USA)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM F] Pine 07:45~08:00 Discussion ()

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM F] Pine 08:00~08:05 Role of Liquid Biopsy in the Management of Hepatocellular Carcinoma 2 Sun Young Yim(Korea Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM F] Pine 08:05~08:15 Clinical Utility of Liquid Biopsy as a Predictive Biomarker in Hepatocellular Carcinoma Yong Han Paik(Sungkyunkwan Univ)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM F] Pine 08:15~08:30 Discussion ()

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 08:30~08:50 Dual Donor Living Donor Liver Transplantation: Orthodox Resolution? Dong-Hwan Jung(Univ. of Ulsan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 08:50~09:10 Graft Inflow Modulation: Surgical vs. Medical Yuji Soejima (Shinshu Univ., Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 09:10~09:30 RAPID/APOLT: Is It a Realistic, Viable Option? Olivier Scatton (Assistance Publique – Hôpitaux de Paris, France)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 11:10~11:25 Mixed Hepatocellular-Cholangiocarcinoma: Epidemiology, Diagnosis, Clinical and Biological Features Hee Yeon Kim(The Catholic Univ. of Korea)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 11:25~11:40 Medical Management for Mixed Hepatocellular-Cholangiocarcinoma: Simple or Not? Jeong-Hoon Lee (Seoul National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 11:40~11:55 KAHBPS: Surgical Management for Mixed Hepatocellular-Cholangiocarcinoma: Is That Different from Hepatocellular Carcinoma? Ho Joong Choi(The Catholic Univ. of Korea)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 11:55~12:10 Transplantation for Mixed Hepatocellular-Cholangiocarcinoma: Prognosis and Related Factors? Jongman Kim(Sungkyunkwan Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 13:10~13:35 The Strategy for Immune Tolerance in Liver Transplantation Hideki Ohdan(Hiroshima Univ., Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 13:35~13:55 Preoperative Desensitization of Cross-Matching Positive and Donor-Specific Antibody Positive Cases in Liver Transplantation Young Rok Choi (Seoul National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 13:55~14:15 Preferred Protocols for ABOi Living Donor Liver Transplantation in Korea and Long-Term Outcomes Gi-Won Song(Univ. of Ulsan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 14:15~14:35 Preferred Protocols for ABOi Living Donor Liver Transplantation in Japan and Long-Term Outcomes Hideki Ohdan (Hiroshima Univ., Japan)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 14:35~14:45 Discussion ()

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 14:45~15:10 Roles of Systemic Treatments of Hepatocellular Carcinoma in the Context of Liver Transplantation Taizo Hibi(Kumamoto Univ., Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 16:10~16:20 Alcoholic Liver Diseases, How to Handle the Waiting List? [Internal Medicine]  Seung Kak Shin(Gachon Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 16:20~16:30 Alcoholic Liver Diseases, How to Handle the Waiting List? [Surgery]  Pyoung Jae Park(Korea Univ)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 16:30~17:10 Panel Discussion Dong Hyun Sinn, Pil Soo Sung,  Ki Tae Yoon, Je Ho Ryu, Nam Joon Yi, Jae Geun Lee (Sungkyunkwan Univ, The Catholic Univ. of Korea, Pusan National Univ, Pusan National Univ, Seoul National Univ, Yonsei Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 17:10~17:20 Hepatocellular Carcinoma, How to Overcome Reverse Discrimination? [Internal Medicine] Eun Ju Cho(Seoul National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 17:20~17:30 Hepatocellular Carcinoma, How to Overcome Reverse Discrimination? [Surgery] Youngin Yoon(Univ. of Ulsan)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM A] The Ballroom A 17:30~18:10 Panel Discussion Kang Mo Kim, Jun Yong Park, Sun Young Yim, Hae Won Lee, Young Seok Han, Dong Jin Joo (Univ. of Ulsan, Yonsei Univ, Korea Univ, Seoul National Univ, Daegu Catholic Univ, Yonsei Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 08:30~08:50 Complementary Roles of Non-and-Invasive Biomarkers for the Assessment of Liver Fibrosis Maria Guido (Univ. of Padua, Italy)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 08:50~09:10 Molecular Characterization of Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis Patients Ju Dong Yang(Cedars Sinai Medical Center, USA)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 09:10~09:30 The Emerging Role of Precision Medicine in the Management of Hepatocellular Carcinoma Jihyun An (Hanyang Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 13:10~13:30 Pathological Consideration in the Era of Immunotherapies Michiie Sakamoto(Keio Univ., Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 13:30~13:50 What We Should Monitor and Handle during Immunotherapies in Hepatocellular Carcinoma Do Young Kim (Yonsei Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 13:50~14:10 Combination Immunotherapy in Intermediate-Stage Hepatocellular Carcinoma Masatoshi Kudo (Kindai Univ., Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 14:10~14:30 Role of scRNA Sequencing in the Era of Hepatocellular Carcinoma Immunotherapy Sun Young Yim(Korea Univ)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 14:30~14:50 Discussion ()

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 14:50~15:10 Biobanks and Registries for Liver and Associated Cancer Research Su Jong Yu(Seoul National Univ)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 16:10~16:30 Sharing Tips for Running an HCC Registry: How Do We Collect and Distribute? [Japanese Experience] Ryousuke Tateishi (Univ. of Tokyo, Japan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 16:30~16:50 Sharing Tips for Running an HCC Registry: How Do We Collect and Distribute? [Taiwanese Experience] Shiu Feng Huang(National Health Research Institutes, Taiwan)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 16:50~17:10 Sharing Tips for Running an HCC Registry: How Do We Collect and Distribute? [Italian Experience] Benedetta Stefanini (Univ. of Bologna, Italy)

±³À°½Ã°£ 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 17:10~17:30 Sharing Tips for Running an HCC Registry: How Do We Collect and Distribute? [Korean Experience] Bo Hyun Kim(National Cancer Center)

Åä·Ð 05¿ù 19ÀÏ ÀÎõ ±×·£µåÇϾæƮȣÅÚ [ROOM BC] The Ballroom B+C 17:30~17:40 Discussion  ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ The Liver Week 2023 Day 2 : 2023-05-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѺñ´¢ÀÇÇÐȸ AUA update 2023 : 2023-05-19
´ÙÀ½±Û (¿Â¶óÀÎ) 2023³â ´ëÇѼҾÆû¼Ò³â°úÇÐȸ 1³âÂ÷ Àü°øÀÇ ¿¬¼ö°­Á : 2023-05-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 35 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 34 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 26 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 30 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 42 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 23 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 25 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 26 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷